1. Torisu M, Katano M, Kimura Y, Itoh H, Takesue M (1983) New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival. Surgery 93:357?364
2. Bast RC, Berek JS, Obrist R, Griffith CT, Berkowitz RS, Hacker NF, Parker L, Lagasse D, Knapp RC (1983) Intraperitoneal immunotherapy of human ovarian carcinoma withCorynebacterium parvum. Cancer Res 43:1395?1401
3. Yasumoto K, Miyazaki K, Nagashima A, Ishida T, Yano T, Suginachi K, Nomoto K (1987) Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. Cancer Res 47:2184?2187
4. Melioli G, Baldini E, Mingari MC, Maria AD, Sertoli MR, Badellino F, Percivale PL, Catturich A, Bertoglio S, Civalleri D, Santi L, Moretta L (1989) Phenotypic and functional characteristics of tumor-associated lymphocytes in patients with malignant ascites receiving intraperitoneal infusions of recombinant interleukin-2(rIL-2). Int J Cancer 43:231?234
5. D'Acquisto R, Markamn M, Hakes T, Rubin S, Hoskins W, Lewis JL (1988) A phase I trial of intraperitoneal recombinant gamma-interferon in advanced ovarian carcinoma. J Clin Oncol 6:689?695